Guido Koch

2.5k total citations
54 papers, 1.9k citations indexed

About

Guido Koch is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Guido Koch has authored 54 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Organic Chemistry, 27 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Guido Koch's work include Chemical Synthesis and Analysis (18 papers), Synthetic Organic Chemistry Methods (12 papers) and Asymmetric Synthesis and Catalysis (11 papers). Guido Koch is often cited by papers focused on Chemical Synthesis and Analysis (18 papers), Synthetic Organic Chemistry Methods (12 papers) and Asymmetric Synthesis and Catalysis (11 papers). Guido Koch collaborates with scholars based in Switzerland, United States and Germany. Guido Koch's co-authors include Andreas Pfaltz, Cara E. Brocklehurst, Paul Knochel, Konstantin Karaghiosoff, Olivier Loiseleur, Ilya S. Makarov, Bruce Clapham, Kim D. Janda, Sang‐Hyeup Lee and Patrick Schnider and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Reviews Drug Discovery.

In The Last Decade

Guido Koch

54 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guido Koch Switzerland 25 1.4k 573 438 284 140 54 1.9k
Francis Gosselin United States 28 1.9k 1.3× 822 1.4× 635 1.4× 247 0.9× 251 1.8× 104 2.5k
S. B. Jennifer Kan United States 21 1.4k 1.0× 1.1k 1.9× 362 0.8× 212 0.7× 110 0.8× 30 2.3k
Simon Berritt United States 20 1.4k 1.0× 497 0.9× 328 0.7× 293 1.0× 210 1.5× 44 2.0k
Stephen D. Roughley United Kingdom 13 2.2k 1.5× 1.1k 2.0× 487 1.1× 198 0.7× 125 0.9× 18 3.0k
Carl A. Busacca United States 28 2.3k 1.6× 611 1.1× 840 1.9× 195 0.7× 99 0.7× 103 2.8k
David M. Tschaen United States 27 2.0k 1.4× 792 1.4× 462 1.1× 186 0.7× 87 0.6× 63 2.5k
Paul Richardson United States 28 1.9k 1.3× 1.1k 1.9× 442 1.0× 448 1.6× 198 1.4× 114 3.1k
Kevin D. Dykstra United States 10 2.1k 1.4× 331 0.6× 377 0.9× 164 0.6× 254 1.8× 17 2.4k
Zhiguo J. Song United States 21 1.2k 0.8× 630 1.1× 221 0.5× 142 0.5× 81 0.6× 59 1.8k
Matthew T. Tudge United States 20 1.9k 1.3× 253 0.4× 554 1.3× 229 0.8× 109 0.8× 30 2.2k

Countries citing papers authored by Guido Koch

Since Specialization
Citations

This map shows the geographic impact of Guido Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Koch more than expected).

Fields of papers citing papers by Guido Koch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guido Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Koch. The network helps show where Guido Koch may publish in the future.

Co-authorship network of co-authors of Guido Koch

This figure shows the co-authorship network connecting the top 25 collaborators of Guido Koch. A scholar is included among the top collaborators of Guido Koch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guido Koch. Guido Koch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naef, Reto, Hermann Tenor, & Guido Koch. (2020). TOP-N53: A Clinical Drug Candidate for the Treatment of Non-healing Wounds. CHIMIA International Journal for Chemistry. 74(10). 814–814. 6 indexed citations
2.
Pulz, Robert, Daniela Angst, Janet Dawson, et al.. (2019). Design of Potent and Selective Covalent Inhibitors of Bruton’s Tyrosine Kinase Targeting an Inactive Conformation. ACS Medicinal Chemistry Letters. 10(10). 1467–1472. 16 indexed citations
3.
Hwang, Ye‐Jin, Connor W. Coley, Milad Abolhasani, et al.. (2017). A segmented flow platform for on-demand medicinal chemistry and compound synthesis in oscillating droplets. Chemical Communications. 53(49). 6649–6652. 69 indexed citations
4.
Makarov, Ilya S., Cara E. Brocklehurst, Konstantin Karaghiosoff, Guido Koch, & Paul Knochel. (2017). Synthesis of Bicyclo[1.1.1]pentane Bioisosteres of Internal Alkynes and para‐Disubstituted Benzenes from [1.1.1]Propellane. Angewandte Chemie International Edition. 56(41). 12774–12777. 196 indexed citations
5.
Koch, Guido, et al.. (2016). Reaction: Synthesis in Drug Discovery, the Short and Long of It. Chem. 1(3). 336–338. 1 indexed citations
6.
Rodrigues, Tiago, N. Hauser, Daniel Reker, et al.. (2014). Multidimensional De Novo Design Reveals 5‐HT2B Receptor‐Selective Ligands. Angewandte Chemie International Edition. 54(5). 1551–1555. 38 indexed citations
7.
Elliott, Luke D., Jonathan P. Knowles, Michael J. Ralph, et al.. (2014). Batch versus Flow Photochemistry: A Revealing Comparison of Yield and Productivity. Chemistry - A European Journal. 20(46). 15226–15232. 167 indexed citations
8.
Schneider, Andreas, et al.. (2012). Rethinking leadership in drug discovery projects. Drug Discovery Today. 17(23-24). 1258–1262. 1 indexed citations
9.
Révész, Láśzló, Achim Schlapbach, Reiner Aichholz, et al.. (2010). In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I. Bioorganic & Medicinal Chemistry Letters. 20(15). 4715–4718. 23 indexed citations
10.
Révész, Láśzló, Achim Schlapbach, Reiner Aichholz, et al.. (2010). In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part II. Bioorganic & Medicinal Chemistry Letters. 20(15). 4719–4723. 27 indexed citations
11.
Velcicky, Juraj, Roland Feifel, Stuart Hawtin, et al.. (2009). Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy. Bioorganic & Medicinal Chemistry Letters. 20(3). 1293–1297. 35 indexed citations
12.
Fuchs, Robyn K., Lothar Leimer, Guido Koch, & M. Westerhausen. (2008). Klinische Erfahrungen mit bakteriell kontaminierten Port-A-Cath-Systemen bei Tumorpatienten. DMW - Deutsche Medizinische Wochenschrift. 112(42). 1615–1618. 1 indexed citations
13.
Schlapbach, Achim, Roland Feifel, Stuart Hawtin, et al.. (2008). Pyrrolo-pyrimidones: A novel class of MK2 inhibitors with potent cellular activity. Bioorganic & Medicinal Chemistry Letters. 18(23). 6142–6146. 35 indexed citations
14.
Jacoby, Edgar, Ansgar Schuffenhauer, Khalil Azzaoui, et al.. (2005). Key Aspects of the Novartis Compound Collection Enhancement Project for the Compilation of a Comprehensive Chemogenomics Drug Discovery Screening Collection. Current Topics in Medicinal Chemistry. 5(4). 397–411. 51 indexed citations
15.
Koch, Guido, Olivier Loiseleur, & Karl‐Heinz Altmann. (2004). Total Synthesis of 26-Fluoro-epothilone B. Synlett. 693–697. 12 indexed citations
16.
Clapham, Bruce, Sang‐Hyeup Lee, Guido Koch, J. Zimmermann, & Kim D. Janda. (2002). The preparation of polymer bound β-ketoesters and their conversion into an array of oxazoles. Tetrahedron Letters. 43(31). 5407–5410. 36 indexed citations
17.
Kottirsch, Georg, Guido Koch, Roland Feifel, & Ulf Neumann. (2002). β-Aryl-Succinic Acid Hydroxamates as Dual Inhibitors of Matrix Metalloproteinases and Tumor Necrosis Factor Alpha Converting Enzyme. Journal of Medicinal Chemistry. 45(11). 2289–2293. 39 indexed citations
18.
Koch, Guido, Guy C. Lloyd‐Jones, Olivier Loiseleur, et al.. (1995). Synthesis of chiral (phosphinoaryl)oxazolines, a versatile class of ligands for asymmetric catalysis. Recueil des Travaux Chimiques des Pays-Bas. 114(4-5). 206–210. 61 indexed citations
19.
Matt, Peter, Olivier Loiseleur, Guido Koch, et al.. (1994). Enantioselective allylic amination with chiral (phosphino-oxazoline)pd catalysts. Tetrahedron Asymmetry. 5(4). 573–584. 152 indexed citations
20.
Koch, Guido. (1973). [Surgery of portal hypertension].. PubMed. 98(15). 545–57. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francis Gosselin Breakdown of academic impact, for papers by S. B. Jennifer Kan Breakdown of academic impact, for papers by Simon Berritt Breakdown of academic impact, for papers by Stephen D. Roughley Breakdown of academic impact, for papers by Carl A. Busacca Breakdown of academic impact, for papers by David M. Tschaen Breakdown of academic impact, for papers by Paul Richardson Breakdown of academic impact, for papers by Kevin D. Dykstra Breakdown of academic impact, for papers by Zhiguo J. Song Breakdown of academic impact, for papers by Matthew T. Tudge
Rankless by CCL
2026